Search

everythinglearnresearchcommunity

for

Search:↓

Temozolomide improves survival in grade III glioma patients without harming quality of life.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Dutasteride helps reduce male pattern hair loss, but may cause side effects like altered libido and erectile dysfunction.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Finasteride effectively treats BPH and hair loss but may cause sexual side effects.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

The drug combination was safe and showed promise in treating advanced tumors.

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.

Minoxidil was first made for high blood pressure, but it was later found to help hair growth.

5% minoxidil foam used once daily is as effective as 2% minoxidil solution used twice daily for hair loss in women, but with fewer side effects like itching and dandruff.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Low-level light therapy significantly increased hair density and thickness in people with hair loss, but they didn't notice a difference.

Applying valproic acid on the scalp increased hair growth in men with hair loss.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Human hair is a significant sample for various tests in clinical, nutritional, archaeological, and forensic studies.

New treatments like nanotechnology show promise in improving skin cancer therapy.

The combination treatment showed a higher response rate but no significant survival benefits.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Microneedles are being used and tested for various medical and cosmetic treatments.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.